Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Casas

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
CNS Drugs|December 7, 2010
Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorderJ Antoni Ramos-Quiroga, Miguel Casas
Psicothema|October 16, 2013
Diagnostic agreement between the Personality Diagnostic Questionnaire-4+ (PDQ-4+) and its Clinical Significance ScaleNatalia Calvo, Fernando Gutiérrez, Miguel Casas
Atencion Primaria|February 24, 2009
[Do we pay sufficient attention to the lack of care of hyperactivity in adults?]Josep Antoni Ramos-Quiroga, Miguel Casas Brugué
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Toward a better understanding of attention-deficit/hyperactivity disorder across the lifespanJ Antoni Ramos-Quiroga, Raquel Vidal, Miguel Casas
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 5, 2010
Attention deficit hyperactivity disorder in adultsMichael Rösler, Miguel Casas, Eric Konofal, et al.
Actas Espanolas De Psiquiatria|August 2, 2012
Prevalence and risk factors of psychotic symptoms in cocaine-dependent patientsCarlos Roncero, Elena Ros-Cucurull, Constanza Daigre, et al.
Adicciones|June 8, 2011
[Epidemiological and diagnostic axis I gender differences in dual diagnosis patients]Laia Miquel, Carlos Roncero, Cristina López-Ortiz, et al.
Adicciones|April 20, 2011
[Smoking in affective psychosis: review about nicotine use in bipolar and schizoaffective disorders]Cristina López-Ortiz, Carlos Roncero, Laia Miquel, et al.
Expert Review of Clinical Pharmacology|March 10, 2017
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Mauro Maccarrone, Rafael Maldonado, Miguel Casas, et al.
Actas Espanolas De Psiquiatria|July 9, 2016
Impulsive clinical profile of Borderline Personality Disorder with comorbid Substance Use DisorderNatalia Calvo, Sergi Valero, Marc Ferrer, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
CNS Drugs|December 7, 2010
Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorderJ Antoni Ramos-Quiroga, Miguel Casas
Psicothema|October 16, 2013
Diagnostic agreement between the Personality Diagnostic Questionnaire-4+ (PDQ-4+) and its Clinical Significance ScaleNatalia Calvo, Fernando Gutiérrez, Miguel Casas
Atencion Primaria|February 24, 2009
[Do we pay sufficient attention to the lack of care of hyperactivity in adults?]Josep Antoni Ramos-Quiroga, Miguel Casas Brugué
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Toward a better understanding of attention-deficit/hyperactivity disorder across the lifespanJ Antoni Ramos-Quiroga, Raquel Vidal, Miguel Casas
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 5, 2010
Attention deficit hyperactivity disorder in adultsMichael Rösler, Miguel Casas, Eric Konofal, et al.
Actas Espanolas De Psiquiatria|August 2, 2012
Prevalence and risk factors of psychotic symptoms in cocaine-dependent patientsCarlos Roncero, Elena Ros-Cucurull, Constanza Daigre, et al.
Adicciones|June 8, 2011
[Epidemiological and diagnostic axis I gender differences in dual diagnosis patients]Laia Miquel, Carlos Roncero, Cristina López-Ortiz, et al.
Adicciones|April 20, 2011
[Smoking in affective psychosis: review about nicotine use in bipolar and schizoaffective disorders]Cristina López-Ortiz, Carlos Roncero, Laia Miquel, et al.
Expert Review of Clinical Pharmacology|March 10, 2017
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Mauro Maccarrone, Rafael Maldonado, Miguel Casas, et al.
Actas Espanolas De Psiquiatria|July 9, 2016
Impulsive clinical profile of Borderline Personality Disorder with comorbid Substance Use DisorderNatalia Calvo, Sergi Valero, Marc Ferrer, et al.
Pageof 15